Managing Advanced Soft Tissue Sarcoma: Do We Have a Mission Impossible? 2016, Volume 11, Number 5
Peter Reichardt HELIOS Klinikum Berlin-Buch, Department of Interdisciplinary Oncology, Cancer Center Berlin-Buch, Berlin, Germany
Soft tissue sarcomas (STS) are a heterogeneous group of rare diseases that encompass more than 50 different histological subtypes. STS constitute a little less than 1% of all cancers in adults, with an estimated incidence averaging 4-5/100,000/year in Europe.